ArticleClinical and translational allergy2017

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial.

Andrzej Bożek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.